chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax 2OCT96 & 2DEC97 pt devel varicella consisting of 20 lesions, fluid-filled vesicles, a low grade fever, swollen & redness of the rt eyelid;
On 04/14/21 I laid down to bed and noticed my tinitus went from moderate to servere. Usually I can notice it if I tried but now could not sleep, can hear it over tv and music. Two weeks later still bad and seems to be increasing.  Also noticed little blood spots showing up on skin on chest, legs, arms. very small, raised, and probably around 20-30 on whole body.
Became violently sick to my stomach. High fever, throwing up, poring sweat but freezing cold, lasted about four hours. Next day I felt extremely sore and very drained with diarrhea.
Autoimmune disorder; This serious case was reported by a consumer via interactive digital media and described the occurrence of autoimmune disorder in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced autoimmune disorder (Verbatim: Autoimmune disorder) (serious criteria GSK medically significant). The outcome of the autoimmune disorder was not reported.   It was unknown if the reporter considered the autoimmune disorder to be related to Shingles vaccine.   It was unknown if the company considered the autoimmune disorder to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient did shingles vaccine and it gave autoimmune disorder. The reporter stated that do not take shingles vaccine. The reporter further stated that it did work anyway. The follow up would not possible as no contact details were available.
mom stated pt ran low grade fever wednesday by thursday lunch temp was 105.4;mom gave motrin  & APAP;had raised rash all over body;had n/v twice;
incorrect vaccine being administered/ maladministration of Kinrix to an 11 year old patient. Kinrix was administered instead of Tdap; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old female patient who received DTPa-IPV (Kinrix) (batch number C472T, expiry date 31-MAR-2024) for prophylaxis.   On 22-JUL-2023, the patient received Kinrix. On 22-JUL-2023, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: incorrect vaccine being administered/ maladministration of Kinrix to an 11 year old patient. Kinrix was administered instead of Tdap). The outcome of the wrong vaccine administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 16-AUG-2023 The nurse reported that the patient was administered the incorrect vaccine. Kinrix was administered instead of the TDAP (Boostrix). No symptoms had been reported due to the incorrect vaccine being administered. The reporter consented to follow up. The patient was given Kinrix instead of Boostrix which led to wrong vaccine administered.; Sender's Comments:  US-GSK-US2023111519:
Patients arm turned red all the way down the arm, but not directly around injection site. She also got a swollen bubble of fluid about the size of a quarter down by her elbow. Applied ice and swelling and redness gradually receding.
Hospitalized with chest pain, shortness of breath, abdominal pain, and bil lower extremity swelling COVID 19 positive.
Patient reported feeling dizzy and lightheaded. Vitals listed below:    1214 - 122/68; 97%; 74; 16 1219 - 110/66; 96%; 74; 18 1225 - 115/63; 96%; 75; 18  Patient was given water/juice and was discharged home in stable condition
Initial misuse report received from a healthcare professional on 01 October 2013. The patient had received FLUZONE HD. Nurse reported that gave only the DTAP/IPV portion to patient. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
Brought to the office on 01/31/09 for inconsolable crying.  No cause for the crying found on exam.  No redness or induration at either injection site. No other illness noted.
no adverse event; expired MMR II was administered; This spontaneous report was received from a clinical office manager and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 22-NOV-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (albumin status rHA) (M-M-R II), 0.5 milliliter, lot # S037501, expiry date 20-NOV-2021 for prophylaxis (route of administration was not provided) (expired product administered). The vaccine did not experience any temperature excursions. No additional adverse event or product quality complaint was reported.
This spontaneous report was received from a register nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided. The reporter stated that on 21-MAY-2018, the patient was vaccinated with a dose of the patient was vaccinated with PROQUAD for prophylaxis (strength, dosage, frequency and route were no provided), lot# reported as M025185, which expired on 18-MAY-2018. No adverse effects reported.
PCR test result: Positive(Nasal Swab)/Since the vaccination, has the patient been tested for COVID-19?:Yes; PCR test result: Positive(Nasal Swab)/Since the vaccination, has the patient been tested for COVID-19?:Yes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm, in Apr2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 05Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 42 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Endometriosis" (unspecified if ongoing); "Fibroid" (unspecified if ongoing), notes: Fibroid; "Known allergy: Penicillin" (unspecified if ongoing). There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 08Oct2022, outcome "unknown" and all described as "PCR test result: Positive(Nasal Swab)/Since the vaccination, has the patient been tested for COVID-19?:Yes". The patient underwent the following laboratory tests and procedures: Polymerase chain reaction: (08Oct2022) Positive, notes: Nasal Swab. Therapeutic measures were taken as a result of covid-19.  Clinical course: Report about COVID treatment: Yes. The most recent COVID-19 vaccine was administered in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. After her booster, she developed heart palpitations/ fluttering a few months after. She went to the emergency room twice due to her fast heartbeat. Doctor or other healthcare professional office/clinic visit. Emergency room/department or urgent care. No treatment AE.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
given expired vaccine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Jul-2021 and was forwarded to Moderna on 06-Jul-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (given expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given expired vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.
20 hours after injection fever of 101 degrees chills body aches lasting for 10 hours30 hours after injection headache dizziness fatigue; 20 hours after injection fever of 101 degrees chills body aches lasting for 10 hours30 hours after injection headache dizziness fatigue; 20 hours after injection fever of 101 degrees chills body aches lasting for 10 hours30 hours after injection headache dizziness fatigue; 20 hours after injection fever of 101 degrees chills body aches lasting for 10 hours30 hours after injection headache dizziness fatigue; 20 hours after injection fever of 101 degrees chills body aches lasting for 10 hours30 hours after injection headache dizziness fatigue; 20 hours after injection fever of 101 degrees chills body aches lasting for 10 hours30 hours after injection headache dizziness fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 24Aug2021 17:30 (Lot number: Ew0187) at the age of 36 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE , Product=COVID 19, Brand=Pfizer, Lot number=Ew0179, Administration date=30Jul2021, Administration time=04:45 PM, Vaccine location=Left arm, Dose number=1), when the patient was 36 years old, for Covid-19 immunisation. The following information was reported: PYREXIA (non-serious), CHILLS (non-serious), PAIN (non-serious), HEADACHE (non-serious), DIZZINESS (non-serious), FATIGUE (non-serious) all with onset 25Aug2021 14:00, outcome "not recovered" and all described as "20 hours after injection fever of 101 degrees chills body aches lasting for 10 hours30 hours after injection headache dizziness fatigue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, chills, pain, headache, dizziness, fatigue.  Additional information: Patient did not receive other vaccine in four weeks and other medications in two weeks. Patient was not diagnosed with COVID-19 prior to and since the vaccination. Patient did not undergo COVID test post vaccination. Patient has no known allergies.  No follow-up attempts are possible. No further information is expected.
At 1715 I experienced numbness on the left side of my back, burning sensation with tingling.  About 20 minutes later that sensation moved up to my shoulder. 10 minutes later moved up the left side of my neck.  It continued to move up and stayed in face, especially lips.  That lasted 30 minutes.  It then moved to include my right nostril, it became stuffy and started to run.    No respiratory distress.  About 45 minutes later the sensation went in my right eye and made it difficult to move it, at this time I also experienced a lot of pain in upper front teeth.  I took Tylenol for the pain. Sensation continued in lips, R nostril, and R eye; along with teeth pain until 6 hours later. After which the numbness in lips lingered for 15 hours total.
second dose of Moderna vaccine reported she had fatique that has been ongoing since vaccine was given. Began day after vaccine. She also had nausea and headache but they subsided after a couple of days but fatique has never subsided.
Patient presented to the ED and was subsequently hospitalized within 6 weeks of receiving COVID vaccination. Diagnosis was pneumonia due to COVID-19 virus.
Itchy rash on trunk, arms and legs, noted on 5/19/00. Mom thought it was bug bites. School teacher thought it was chicken pox. Seen in MD office on 5/22/00 with bumpy red rash with vesicles. Symptomatic reaction. Spoke with mom on 5/24/00 and child home from school, feeling ok.
After receiving the second and third COVID boosters patient had stroke like symptoms, unable to talk, stay alert, walk. She is slowly coming out of the symptoms but remains very lethargic.
Breakthrough case admission after 2 vaccines ; MOderna 2/23/21 Lot# 023M20A;  Moderna 3/23/21 lot# 047A21A;
tested positive for covid on       2-4-22      , deceased on        3-2-22    .  Admitted at local hospital on     2-13-22     with resp failure, covid pneumonia and abd pain.    Notes show she was transferred to alternate hospital by air ambulance and underwent cardiac arrest.  on mech ventilation, hyperkalema and for dialysis.  sx resp failure, cardiac arrest and hyperkalemia.
1st shot 4/27.  Friday, about 10 days later, felt pain at injection site that lasted a few days.  Felt woozy and a little dizzy, and that continues - though has lessened. (I cancelled a meeting because of it.)    Left shoulder feels tense. Sleep and aspirin helps.  I have more energy today.  Google says these side effects are common, but usually start right away or during first few days.  I could not find anything about these side effects starting 10 days after the injection.
10 cm red tender induration, area was warm with no drainage right deltoid 3 days post vaccine (6/18/07
feeling disoriented; Confused; unable to put words together; This is a spontaneous report from a contactable consumer (patient). A female patient (Age: 82; Unit: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number was not reported), via an unspecified route of administration on 06Feb2021 as single dose for covid-19 immunization. Medical history included TIA/ministroke. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced feeling disoriented, confused, unable to put words together. It was reported that events experienced shortly after receiving her vaccine She went to the ER and they concluded it was not a stroke. She wanted to know if she can get the second vaccine. The outcome of events was unknown.  Information about lot/Batch number has been requested.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a nurse, concerning an unknown number of patients, of an unknown gender and age. Medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with a dose of GARDASIL. Co-suspect and concomitant therapies were not reported. The nurse reported that an unknown number of patients were inadvertently administered GARDASIL that had been improperly stored. No adverse effects reported. This is one (1) of 2 (two) reports from the same source (MARRS 1408USA009360 and 1407USA013091). Additional information has been requested.
dental pain; fatigue; headache; loss of taste; loss of smell; body aches; This is a spontaneous report from a contactable consumer. A 71-year-old female patient received bnt162b2 (BNT162B2), via intramuscularly on 13Jan2021 at single dose for covid-19 immunisation. Medical history included ongoing ankylosing spondylitis and potentially being exposed to COVID. The patient's concomitant medications was not reported. Patient began to have symptoms of COVID on 16Jan2021. The symptoms include Body aches, headache, loss of taste, loss of smell, dental pain, and fatigue. Hence on 22Jan2021 the patient hospitalized and same day had discharge, the patient had, blood sampling, X-ray, oxygen, and intravenous fluid. The patient underwent lab tests and procedures which included blood test: unknown result on 22Jan2021, x-ray: unknown result on 22Jan2021. The outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
about 10 hours after administration. I spiked a fever of 102.4. it would not  change. down below 101 for 12 hours with acetaminophen. I had body pain, severe  joint pain , Every muscle and joint hurt. It was to the  point, that I could not get up on my own. This gradually improved, but would  flare up if my temp went above 101,   severe abdominal pain,intense for about 24 hours. It began gradually approximately 10 hours after getting the injection. It felt more like spasms as compared to gastrointestinal pain.    My arm...where I had the injection was so painful, I  could not raise it. I had  and continue the have painful joints.   very dark urine for about 36 hours despite drinking lots of fluids    I also have bra
Day 8 - redness 3 inch diameter at injection site, hot to tough and slight knot
Information has been received from a physician concerning a 36 month old white female who on 26NOV2001 was vaccinated in the right arm with a first dose of varicella virus vaccine live. Concomitant vaccination the same day included a first dose of measles virus vaccine live + mumps virus vaccine live + rubella virus vaccine live given in the left arm. There was no illness at the time of vaccination. On 08SEP2003 the patient developed a mild case of chickenpox. It was reported that the rash lasted 3-4 days. It was reported that the pt was previously vaccinated with hepatitis B virus vaccine rHBsAg + Hib conj vaccine, penumococcal  conj vacine (PREVNAR), polio virus vaccine inactivate VERO (IPOL) and diphtheria toxoid + pertussis acellular 3-component vaccine + tetanus toxoid (INFANRIX). No further information is available.
Patient states she developed a red and swollen arm, arm pain and itching, brain fog, and nausea/stomach issues. Her symptoms resolved within 3-4 days.
Information has been received from a registered nurse and from a mother concerning her approximately 35 months old son with oesophageal acid reflux, allergies to Penicillin and to environment and autism diagnosed when he was only 18 months old following the vaccination with hepatitis B virus vaccine (MSD, WAES# 0903USA04681). In 2005, the patient was vaccinated with ATTENUVAX (lot# not reported) when he was 2 and a half years old. Later on when the patient was 2.9 years old (in 2005), the patient was diagnosed with "Kawasaki disease". It was reported that the patient had fever that ran 102 for 5 days, strawberry like color of tongue and throat, dry and cracked lips, his eye was pink but no discharge and he had swollen hands and feet. The patient was hospitalized in March 2005 for 4 nights. The mother added that the patient developed urinary tract infection later on and was hospitalized again in April 2005 for "maybe 3 days" at the same hospital. The patient was given intravenous immunoglobulin treatment and aspirin therapy for 6 months after hospitalization. Unspecified blood work was performed (result unknown). Additional information has been requested.
Day 0-no symptoms, Days 2-3 muscle aches, extreme fatigue, diarrhea, no appetite, headache. Days 4-6, fatigue, headache.
Patient was given the 11 year vaccines and about 3 minutes after he felt very light headed and slowly started to fall. Mom was right by his side. Immediately mom called for staff, MA went to assist while other MA went to get provider. While laying on the floor patient vomited. Provider assessed  patient, vitals were taken. Mom wanted for patient to be observed in ER and a non emergency transport was called. Mom declined the transport due to patient feeling better.
Information has been received from a nurse, referring to a patient (gender and age unknown). Information about medical history, concurrent condition and concomitant therapy was unknown. On 20-AUG-2018, the patient was vaccinated with a dose of Oka-Merck PROQUAD injection (strength, route and frequency unknown; a dose, lot# N000336, expiration date: 30-JUL-2018, therapy type: recombinant Human albumin (rHA)) for unknown indication (expired product administered). No adverse effects were reported. Follow-up information was received on 04-SEP-2018. This spontaneous report is regarding a 5 year old male patient. The patient was vaccinated with Oka-Merck PROQUAD in the left upper arm. Other suspect therapies included KINRIX (Lot # 75153, Expiration date unknown) in the left deltoid arm for prophylaxis.
Patient received her first dose of Moderna Covid-19 vaccine on 04/11/2021. Patient arrived for her second dose on 05/09/2021. Upon check-in, it was noticed that her birthdate was entered incorrectly in the primary bio computer system.  The mother of the patient was in the car and mentioned that she registered the patient under her own birthday.  When changing the patient's birthday to the correct date, it was recognized that the patient was only 17 years old and not yet approved for the Moderna Covid-19 vaccine. Medical Hotline was called as well as the Moderna manufacturer.  The physician and the manufacturer agreed that since the patient did not have an adverse reaction to the first dose of the vaccine, that she would be able to receive the second dose to complete the series.  The second dose was administered to the patient on 05/09/2021. The patent was observed afterwards. No adverse reaction.
sick for a week; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. Other Case identifier(s): US-PFIZER INC-202101312069 (Pfizer).  A 49 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 immunization. The following information was reported: ILLNESS (non-serious), outcome "recovered" (2021), described as "sick for a week".  Additional information: The patient was in good shape, he was an active person. He was one of those people who didn't have any health concerns. He was pretty healthy and active. The patient had some side effects from his second Pfizer vaccine and he had it go on for almost 2 weeks. The patient felt the 2nd dose very strong. The patient was sick for at least a week with the second dose and he felt terrible after the second dose but he was good, he didn't have COVID. He said 10 days or 12 days, he had to take time off from work and he was fine now.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient got half dose; A spontaneous report was received from a pharmacist for a female patient who received Moderna's COVID-19 vaccine (mRNA-1273). The patient received half dose.  The patient's medical history was not provided. No concomitant product use was reported.  On 24 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection. It was known that the needle used to administered vaccine was loose hence the patient received half of the dose.  Treatment information was not applicable.  Action taken with mRNA-1273 was not applicable.  The outcome of the event was not applicable.; Reporter's Comments: This report refers to a case of underdose and syringe issue for mRNA-1273 (lot # unknown) with no associated AEs reported.
pt died of SIDS 6JAN93 p/hosp attempt to revive; case #940067; Autopsy done 7JAN94;
Severe left deltoid pain and localized induration without redness starting 10 hrs after immunization.
Patient was ordered KINRIX by Doctor but was given PEDIARIX by Medical Assistant. Patient was two months early for Hepatitis B dose.